2001
DOI: 10.1007/bf02752421
|View full text |Cite
|
Sign up to set email alerts
|

Kawasaki disease—Indian perspective

Abstract: Kawasaki disease is a syndrome of unknown etiology affecting children below 5 years of age and is a leading cause of acquired heart disease in many developed countries. Incidence of this disease in India is extremely low as evidenced by the meagre case reports. Complications due to this disease in Indian patients are still rarer. Here we report two cases of Kawasaki disease both of whom had a benign course. A comparison of this disease in Indian and Western literature shows that the incidence of cardiac compli… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2012
2012
2019
2019

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 9 publications
0
2
0
Order By: Relevance
“…[2] Among the first reported compounds from this family of structurally related molecules are integrin (4) and oxyisocyclointegrin (5). [3] It is not clear if oxyisocyclointegrin (5) exists as a racemate or as a single stereoisomer as no optical rotation data has been reported. To the best of our knowledge no biological activity data for either 4 or 5 has been reported in the literature.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…[2] Among the first reported compounds from this family of structurally related molecules are integrin (4) and oxyisocyclointegrin (5). [3] It is not clear if oxyisocyclointegrin (5) exists as a racemate or as a single stereoisomer as no optical rotation data has been reported. To the best of our knowledge no biological activity data for either 4 or 5 has been reported in the literature.…”
Section: Introductionmentioning
confidence: 99%
“…The synthetic material was spectroscopically equivalent to that reported for the isolated natural product. [3] Vinylpyran 19, integrin (4) and oxyisocyclointegrin (5) were found to possess moderate to weak activity against Staphylococcus aureus (Table 1). Oxyisocyclointegrin (5) possessed weak activity against prostate cancer cells (LnCap).…”
Section: Introductionmentioning
confidence: 99%